当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Omer Aliyi, Mohammed Hussien and Belayneh Kefale
Background: Diabetes Mellitus (DM) is a group of common metabolic disorders that share the phenotype of hyperglycemia. Half century ago hydrochlorothiazide has been associated with a diagnosis of diabetes in hypertension treatment containing hydrochlorothiazide during long term therapy. This explained by association between glucose, potassium, and hydrochlorothiazide induced hyperglycemias and plasma insulin level. The objective of this study was to assess the problem associated with use of hydrochlorothiazide among adult diabetic patient in diabetic clinic of AHMC.
Methodology: A cross sectional study was carried out by reviewing patient information sheet and physician diagnosis card with a period from March, 25-May, 28, 2014. Data was collected from patient information sheet and physician diagnosis card by using check list and collected data was analyzing by using SPSS-20.
Result: In this study population the total of 1,200 patient cards with hypertension and type-2 diabetes were observed, from which only 60 patient have a problem associated with hydrochlorothiazide diuretic. Among these patient 55% were female and 38.3% were in the age group of 40-50 years and mean age was 51 years. Most of patient, 82% patient had increased FBS after HCT administration and around 90% of patient had decreased FBS after HCT discontinuation. Among the total number of the cases only in 5% showed high response to insulin and 37% low response to insulin. Most of the patient around 70% develop problem associated with HCT within start to six month.
Conclusion: In general in this study indicated that elevated fasting serum glucose level was the main problem associated with the use of HCT in adult diabetic patient